Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy H Perlis

Showing results (251-260 of 414) with videos related to

Pageof 42
Sort By:
Medrxiv : the Preprint Server for Health Sciences|June 10, 2024
Stratifying Risk for Postpartum Depression at Time of Hospital DischargeMark A Clapp, Victor M Castro, Pilar Verhaak, et al.
Psychiatric Services (Washington, D.C.)|June 28, 2019
Evidence of Low Adherence to Stimulant Medication Among Children and Youths With ADHD: An Electronic Health Records StudyJoseph Biederman, Ronna Fried, Maura DiSalvo, et al.
Psychopharmacology|June 28, 2020
Further evidence of low adherence to stimulant treatment in adult ADHD: an electronic medical record study examining timely renewal of a stimulant prescriptionJoseph Biederman, Ronna Fried, Maura DiSalvo, et al.
Nature Medicine|June 4, 2021
Phenotypic signatures in clinical data enable systematic identification of patients for genetic testingTheodore J Morley, Lide Han, Victor M Castro, et al.
BMJ Mental Health|January 21, 2026
Antidepressant use among American adults in a 50-state surveyRoy H Perlis, Anudeepa K Ramachandiran, Pilar F Verhaak, et al.
Journal of Clinical Psychopharmacology|September 28, 2002
Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorderRoy H Perlis, Andrew A Nierenberg, Jonathan E Alpert, et al.
The Journal of ECT|March 3, 2009
Efficacy of electroconvulsive therapy in Fahr disease associated with bipolar psychotic disorder: a case reportFrancesco Casamassima, Lorenzo Lattanzi, Roy H Perlis, et al.
The Journal of Clinical Psychiatry|July 18, 2006
A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depressionSara A Corya, Roy H Perlis, Paul E Keck, et al.
Obesity (Silver Spring, Md.)|February 14, 2024
Offspring cardiometabolic outcomes and postnatal growth trajectories after exposure to maternal SARS-CoV-2 infectionLydia L Shook, Victor M Castro, Emily M Herzberg, et al.
The Journal of Clinical Psychiatry|February 8, 2007
Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implicationsCristina Cusin, Maurizio Fava, Jay D Amsterdam, et al.
Pageof 42

Showing results (251-260 of 414) with videos related to

Sort By:
Pageof 42
Medrxiv : the Preprint Server for Health Sciences|June 10, 2024
Stratifying Risk for Postpartum Depression at Time of Hospital DischargeMark A Clapp, Victor M Castro, Pilar Verhaak, et al.
Psychiatric Services (Washington, D.C.)|June 28, 2019
Evidence of Low Adherence to Stimulant Medication Among Children and Youths With ADHD: An Electronic Health Records StudyJoseph Biederman, Ronna Fried, Maura DiSalvo, et al.
Psychopharmacology|June 28, 2020
Further evidence of low adherence to stimulant treatment in adult ADHD: an electronic medical record study examining timely renewal of a stimulant prescriptionJoseph Biederman, Ronna Fried, Maura DiSalvo, et al.
Nature Medicine|June 4, 2021
Phenotypic signatures in clinical data enable systematic identification of patients for genetic testingTheodore J Morley, Lide Han, Victor M Castro, et al.
BMJ Mental Health|January 21, 2026
Antidepressant use among American adults in a 50-state surveyRoy H Perlis, Anudeepa K Ramachandiran, Pilar F Verhaak, et al.
Journal of Clinical Psychopharmacology|September 28, 2002
Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorderRoy H Perlis, Andrew A Nierenberg, Jonathan E Alpert, et al.
The Journal of ECT|March 3, 2009
Efficacy of electroconvulsive therapy in Fahr disease associated with bipolar psychotic disorder: a case reportFrancesco Casamassima, Lorenzo Lattanzi, Roy H Perlis, et al.
The Journal of Clinical Psychiatry|July 18, 2006
A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depressionSara A Corya, Roy H Perlis, Paul E Keck, et al.
Obesity (Silver Spring, Md.)|February 14, 2024
Offspring cardiometabolic outcomes and postnatal growth trajectories after exposure to maternal SARS-CoV-2 infectionLydia L Shook, Victor M Castro, Emily M Herzberg, et al.
The Journal of Clinical Psychiatry|February 8, 2007
Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implicationsCristina Cusin, Maurizio Fava, Jay D Amsterdam, et al.
Pageof 42